September 22, 2021 10:44 US Eastern Time | Source: Bolder Surgical Holdings Bolder Surgical Holdings
Louisville, Colorado, September 22, 2021 (Global News Service)-Bolder Surgical today announced the global launch of the CoolSeal™ Vascular Sealing Platform. CoolSeal has been in use in the United States since October 2020. With the approval of the new international regulatory agency, the device can be used in more than 20 countries/regions around the world.
Bolder Surgical provides surgeons with precision electrosurgical instruments to safely and effectively perform minimally invasive surgery in pediatric and adult surgery, including general, gynecological and bariatric surgery applications.
The CoolSeal Vessel Sealing kit includes 3 mm Mini (formerly known as JustRight Sealer) and 5 mm Trinity Sealer/Divider/Dissector. Both devices use the gold standard efficacy of advanced bipolar radiofrequency vessel sealing technology.
"The Trinity 5 mm device has successfully used the 3 mm vessel sealer in many cases of pediatric surgery, and it is an excellent addition to the surgical instrument I chose," said Dr. Satoshi Ieiri, a pediatric surgeon at Kagoshima University Hospital. "Slim, curved mandibular design and increased sealing capabilities support older children, adolescents, and adults. It is a truly all-in-one instrument that enables precise anatomy and rapid sealing time with minimal heat distribution And a huge advantage."
The CoolSeal device has an average heat dissipation of less than 1 mm and uses a slim double-action jaw, which combines the ingenuity of a true surgical instrument with the gold standard efficacy of advanced bipolar radiofrequency vessel sealing. These devices are designed for versatility, which means fewer instrument changes, which helps simplify workflow and reduce operating time.
Bolder Surgical continues its path of innovation through investments focused on research and development, allowing the company to transcend its origins in pediatric equipment. "We have successfully used our expertise in microsurgery equipment and energy delivery to create the CoolSeal product portfolio," said Robert Kline, President and CEO of Bolder Surgical. "The product portfolio aims to provide surgeons with innovative, versatile options that minimize the impact of surgery, from the smallest patients to teenagers and adults. We are very proud that doctors around the world can now use this innovative technology."
CoolSeal products are now available in more than 20 countries/regions around the world, including EU member states, the United Kingdom, Japan, Australia and the Middle East. For information, please visit BolderSurgical.com.